Colin Lin

Colin Lin is a seasoned professional in business development and product management, currently serving as the Senior Director of Business Development at Alphamab Oncology since April 2021. Previously, Lin held the position of Associate Director of Business Development at 卫材 from January 2018 to April 2021 and worked as a Senior Business Development Manager at Eddingpharm for a brief period in 2017. Lin's earlier experience includes significant roles at 勃林格殷格翰 as a Senior Product Manager, where strategic brand planning led to a leading position in the market, and earlier roles at 强生公司 and Novartis Vaccines. Academic qualifications include a Master's degree in biotechnology and medication from the University of Chinese Academy of Sciences, an MBA from the China Europe International Business School, and participation in an international exchange program in AP Macroeconomics at Princeton University.